California woman finds ways to control IBS
July 5, 2012 By Serena Gordon, HealthDay Reporter in Diseases, Conditions, Syndromes
Careful eating, practicing yoga and not internalizing stress prove key to her success.
(HealthDay) -- Rachel Byrd doesn't remember a time before she had stomach pain and digestive issues. But her symptoms got so bad in 2009 that she rushed to the hospital, thinking her appendix had burst because the pain was so intense.
As it turned out, Byrd didn't need surgery. Doctors did diagnose her with irritable bowel syndrome (IBS), though she said it wasn't as straightforward as getting a blood test and then getting a diagnosis.
"They have to rule out everything else before diagnosing IBS," said Byrd, now 26 and living in San Francisco. "It's not an exact science." She had a CT scan and other tests and said that "they didn't find anything else wrong, so by my symptoms and ruling out everything else, they were able to diagnose IBS."
Initially, Byrd tried taking fiber supplements to control her IBS symptoms, but she said they made her feel bloated and upset her stomach. Today she manages her symptoms by watching what she eats, doing yoga and doing her best to keep her stress levels in check.
"I went to a nutritionist and really changed the way I was eating," she said. "I cut out processed foods and ate more whole foods high in fiber. I also had to give up coffee completely."
For Byrd, stress at work tends to be the most frequent cause of symptom flare-ups. "I may not eat as well as I should if I'm stressed," she said. "Now I know that if there's going to be a lot of stress at work, I try to make sure that I don't have a lot of caffeine. I also try to be more conscious about what I'm eating and make time for exercise."
For anyone just diagnosed with IBS, "it's important to find a health-care provider that you can work with closely on a management plan," Byrd said. "Read up, read everything you can and try to follow the guidelines on what foods to eat."
And one more thing: "Try to find ways to not internalize stress," she said.
"For so long before I was diagnosed, I was eating and drinking things daily that made my symptoms worse," Byrd said. "Eliminating things made my symptoms so much better. It was kind of surprising. You have to figure it out through trial and error, and that was hard. But if I watch what I eat, and I'm able to do something active every day, I see a big improvement."
Treating irritable bowel poses challenges
As many as one in five Americans has to deal each day with symptoms of irritable bowel syndrome, a digestive disorder for which treatment options remain limited.
"Treatment is challenging because we have only one approved drug from the FDA [U.S. Food and Drug Administration] right now," explained Dr. Satish Rao, director of the Digestive Health Center at Georgia Health Sciences University and Health System.
But there's good news, too, he said, because non-drug ways do exist to help control symptoms and several new drugs are in the pipeline. And though IBS, as it's called, can significantly affect people's quality of life, Rao said it doesn't damage the bowels and "nobody dies from IBS."
The most common symptoms of IBS are abdominal pain or discomfort and altered bowel function, according to Rao.
Dr. William Sandborn, chief of gastroenterology at the University of California San Diego Health System, explained that IBS "is more of a problem in the muscles and the nerves of the bowel."
"If you have problems with the bowel contracting too much, you'll have cramping and diarrhea," he said. "If the bowel doesn't contract enough, the contents of the bowel won't move forward sufficiently, and you'll have constipation."
If you have diarrhea associated with abdominal symptoms, doctors will refer to your disorder as diarrhea-predominant IBS. If constipation is more of an issue, you have constipation-predominant IBS. Those who experience both diarrhea and constipation have what's called mixed IBS.
Exactly what causes IBS remains a mystery -- or what Rao called "the million dollar question."
"We have unearthed some factors," Rao said. "It looks like people with certain genes are predisposed to IBS, and environmental factors play a role. Changes in the gut flora [the types of bacteria in the intestine] may predispose you to IBS." He also said that some people develop IBS after having a viral or bacterial infection. That's called post-infectious IBS.
Some people also have dietary intolerances to substances such as fructose, he said, and those symptoms can mimic IBS.
One factor that definitely does not cause IBS, Rao said, is stress -- though he said it could trigger symptoms in people who already have the digestive disorder.
A specific diagnostic test doesn't exist for IBS so to diagnose it, doctors must rule out other potentially more serious causes of digestive symptoms, such as colon cancer or Crohn's disease. Methods used to do this, Sandborn and Rao said, include blood tests, CT scans, a hydrogen breath test, endoscopy and colonoscopy.
Treatment generally aims to ease symptoms. People whose major problem is diarrhea may be given fiber supplements and possibly anti-diarrheal medications, according to Sandborn. For those whose main symptom is constipation, a doctor might suggest stool softeners.
Sandborn cautioned that people with IBS should "try to avoid stimulant laxatives as these can damage the bowel if used chronically." But he said that natural, beneficial bacteria known as probiotics -- whether from yogurt or a supplement -- may help ease some IBS symptoms.
Dietary changes also may help, but there's "not a perfect diet for this that helps everyone," Sandborn said. He suggested working with a nutritionist to try to eliminate foods that might trigger symptoms while still maintaining a balanced diet.
On the medication front, the antibiotic rifaximin, which is prescribed for traveler's diarrhea, may prove helpful for some people with IBS, though Sandborn said it's currently not approved for this use. Another medication that's being investigated for use in IBS with constipation and is currently under review by the FDA is linaclotide.
The only FDA-approved drug for IBS is alosetron (Lotronex), which was approved for IBS with diarrhea. But because of serious potential side effects, its use is restricted and only certain doctors are allowed to write prescriptions for it. Another IBS drug, tegaserod (Zelnorm), was pulled from the U.S. market several years ago and is now available through the FDA only in emergencies that are life-threatening or require hospitalization. Sandborn said it had been linked to a rare but increased risk for heart attack.
Irritable bowel "is an illness that doesn't look like a major disease, but it significantly affects quality of life," Rao said. "We have to tailor treatment to the needs of the patient, and that often includes a whole host of wonderful people like doctors, nutritionists, pain specialists and more, depending on the situation and the patient's needs."
Copyright © 2012 HealthDay. All rights reserved.
-
Biomarkers can reveal irritable bowel syndrome
May 07, 2012 |
not rated yet |
0
-
Hypnotherapy eases irritable bowel syndrome symptoms
Mar 18, 2010 |
not rated yet |
0
-
Peppermint earns respect in mainstream medicine
Apr 19, 2011 |
not rated yet |
0
-
Common bowel problem linked to chili pepper pain receptor
Jun 10, 2008 |
not rated yet |
0
-
New book from the AGA helps patients achieve greater freedom from IBS
Oct 13, 2010 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Researchers find genetic risk factor for pulmonary fibrosis
A paper recently published in the New England Journal of Medicine and co-written by physicians and scientists at the University of Colorado School of Medicine finds that an important genetic risk factor for pulmonary fibros ...
Diseases, Conditions, Syndromes
7 minutes ago |
not rated yet |
0
Biomarkers discovered for inflammatory bowel disease
Using the Department of Defense Serum Repository (DoDSR), University of Cincinnati (UC) researchers have identified a number of biomarkers for inflammatory bowel disease (IBD), which could help with earlier diagnosis and ...
Diseases, Conditions, Syndromes
8 minutes ago |
not rated yet |
0
CDC says high number of public pools contain microbes
(HealthDay)—Three-quarters of public schools in the metro Atlanta area contain microbes, including bacteria indicating the presence of fecal matter, according to research published in the May 17 issue of ...
Diseases, Conditions, Syndromes
1 hour ago |
not rated yet |
0
Study examines outbreak of spinal infections in Michigan
(HealthDay)—Factors such as increased case finding may explain why Michigan had half of the total spinal infections associated with contaminated methylprednisolone acetate in the recent fungal meningitis ...
Diseases, Conditions, Syndromes
1 hour ago |
not rated yet |
0
World not ready for mass flu outbreak, WHO says
The world is unprepared for a massive virus outbreak, the deputy chief of the World Health Organization warned Tuesday, amid fears that H7N9 bird flu striking China could morph into a form that spreads easily among people.
Diseases, Conditions, Syndromes
1 hour ago |
not rated yet |
0
Reducing caloric intake delays nerve cell loss
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
Changing cancer's environment to halt its spread
By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...
Global recommendations on child medicine
Transparent information on the evidence supporting global recommendations on paediatric medicines should be easily accessible in order to help policy makers decides on what drugs to include in their national drug lists, according ...
Novel RNA-based classification system for colorectal cancer
A novel transcriptome-based classification of colon cancer that improves the current disease stratification based on clinicopathological variables and common DNA markers is presented in a study published in PLOS Medicine this w ...
H. pylori, smoking trends, and gastric cancer in US men
Trends in Helicobacter pylori (H. pylori) and smoking explain a significant proportion of the decline of intestinal-type noncardia gastric adenocarcinoma (NCGA) incidence in US men between 1978 and 2008, and are estimated ...
Post-approval TAVI registry shows high rates of device success at one year
One-year results from SOURCE XT – one of the largest, post-approval transcatheter aortic valve implantation (TAVI) registries to-date – reported today at EuroPCR 2013 show good clinical outcomes in routine clinical practice, ...